RxDoctor Payments Data

Gary Gross

Allergy · Dallas, TXNPI 1285601336

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $451,393 of the $602,218 with a category attached, or 75.0%. 43 manufacturers reported payments, led by Sanofi at 33.3% of the total. Among allergy clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$602,218in general payments, 2019–2025

Across 1,162 payments — averaging $518.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$200K
  • Regeneron Healthcare Solutions, Inc.$173K
  • AstraZeneca$115K
  • Optinose US, Inc.$28K
  • Merck$22K
  • Teva Pharmaceuticals USA, Inc.$15K
  • plus $49K from 37 others
$3,120,424in research payments, 2019–2025

Across 439 payments — averaging $7108.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$984K
  • GSK$549K
  • Teva Pharmaceuticals USA, Inc.$337K
  • Sanofi US Services Inc.$251K
  • Novartis$248K
  • Genentech, Inc.$228K
  • plus $523K from 9 others

What the payments were for

  • Consulting fees$60,24510%
  • Speaking & faculty fees$451,39375%
  • Travel & lodging$65,00611%
  • Food & beverage$25,3894%
  • Education$1850%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$602,218 in reported general payments places this provider in the 95th percentile of 69 allergy providers in Texas.

See all allergy providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Montelukast Sodium11$124

Paid to pharmacies, not to this prescriber.

Other allergy in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →